Search


Scancell's CEO discusses her company's cancer immunotherapy programs
Lindy Durrant describes Scancell's DNA and peptide based vaccine programs, as well as early stage antibody work.
May 3, 2024
Also look for unique social pages for BiotechTV U.
Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.